Letters
Screening for atrial fibrillation
Screening for atrial fibrillation: waiting for randomised trial data
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2383 (Published 04 June 2019) Cite this as: BMJ 2019;365:l2383
- Robert Steele, independent chair,
- John Marshall, evidence lead,
- Anne Mackie, director of screening
- UK National Screening Committee, London SE1 8UG, UK
- r.j.c.steele{at}dundee.ac.uk
We agree with Berge that Wilson and Jungner would not approve of screening for atrial fibrillation.1 The key problems are that we do not know whether screen detected atrial fibrillation carries the same risk of stroke as disease that is clinically detected …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.